Prevention and Wellness: Sanofi US Partners with National Organizations
Some of the more vocal members of the Diabetes Online Community have asked that I do more to introduce you to others who work here at Sanofi US and I could not be more thrilled to oblige. After all, we want your input to help shape the content we publish! Angela Moskow has spent a total of 22 years at Sanofi US and for a number of those years guided our efforts in marketing to those living with diabetes.
Last year, Angela transitioned to Vice President of Chronic Disease Prevention, Wellness & Innovation. While her current focus still touches diabetes, she is now working to help prevent a number of chronic diseases in the U.S. She’s leading the way on some inspiring and innovative work and I’m excited to share the projects she’s heading up with you.
Q: Before moving into your current role you were Head of Insulins Marketing for US Diabetes. What did you take away from that position that you find yourself applying to your current role?
A: I have been fortunate to work in the area of diabetes for the last 17 years. I have seen a lot of changes in the treatment area and an explosion of new options for people with diabetes. One thing that has not changed is the support this community provides to one another. It is very exciting to see technology make this support even more accessible to so many. I certainly am proud of the diabetes products we have brought to so many people, but I am still very dismayed at how quickly the diabetes rate has risen – and continues to – in the U.S. There is a huge need for additional work in the area of prevention and I am passionate about making an impact and potentially helping millions more in the future.
Q: What is your charge in your current position and what are your top priorities?
A: I have transferred to building a plan to help prevent chronic disease and chronic disease progression. So, for example, instead of working in an area of treatment when someone has already developed diabetes, I will be addressing how to help people avoid developing diabetes. Prevention is so critical to the future health of our nation. I will focus in the areas of childhood obesity as well as reversing the trend of increased diabetes diagnosis in the U.S.
Q: Why is it important that Sanofi US help prevent diseases like diabetes, and not just help to treat them?
A: Over the past three years, Sanofi US has embarked on and has been implementing a diversification strategy to be more than just a world class pharmaceutical company, to become a leading healthcare solutions company. In order to be successful in this strategy, we need to look beyond today’s products and broaden our overall offering to the healthcare community. Chronic disease prevention and wellness must be part of this diversification if we are truly going to address the overall health of our nation. The dollars being spent in chronic disease, three out of every four healthcare dollars today, are unsustainable. We want the company to be part of the solution in reversing this.
Q: Can you tell us about some of the ways Sanofi US is partnering with other organizations to help with prevention and wellness?
A: I’m pleased with our initial outreach and engagement efforts in our partnership building. Thus far, we have a pretty impressive group of partners who are leaders in the chronic disease prevention and wellness arena.
Since 2007, Sanofi US has supported and partnered with the STOP Obesity Alliance, a coalition of consumer, provider, government, labor, business, health insurers, and quality-of-life organizations united to drive innovative and practical strategies to combat obesity. The Alliance’s goal is to go beyond awareness and consumer education efforts to identify and address systemic and cultural barriers that are failing to adequately support and recognize obesity as a serious health condition.
Through its collaboration with George Washington University, the Alliance conducts research and provides recommendations to help shape policy decisions related to health and obesity. For example, last December, the Centers for Medicare and Medicaid Services (CMS) announced that Medicare will cover screenings and preventive services to help recipients address obesity and weight-related issues including diabetes as well as heart disease. This decision is in part a culmination of work from many organizations, including the Alliance, to educate policymakers and other important stakeholders about the need to create multi-pronged approaches to prevent and treat obesity.
This year the Alliance will continue to be an influential voice for informing policy and advancing research to evaluate new prevention and treatment strategies. Two major priorities this year include working with state leaders as they prepare for health care reform and the implementation of the Affordable Care Act and expanding its focus to include the role of women and families in addressing childhood obesity.
Q: Are there other examples of the prevention efforts Sanofi US is currently involved with?
A: In our Primary Prevention efforts, which focus on childhood obesity and diabetes, we’ve engaged many organizations committed to reversing the trends of these two epidemics among our youth. Just to highlight a few, we work with:
- The Alliance for a Healthier Generation (AHG), an initiative of the Clinton Foundation, focused on empowering kids nationwide to make healthy lifestyle choices when in school, at home, at the doctor or in the community through one of the AHG’s three programs.
- The Partnership for a Healthier America (PHA), which is a spring board of The First Lady’s signature platform program, Let’s Move! PHA is devoted to working with the private sector to ensure the health of our nation’s youth by bringing together public, private and nonprofit leaders to broker meaningful commitments and develop strategies to end childhood obesity.
- Dr. Oz’s group, HealthCorps, which is a national service and peer mentoring initiative. In high schools, HealthCorps “coordinators” empower teens in underserved populations to make simple lifestyle changes to enhance their well-being and resilience and take the message to friends, families and neighbors.
These are all groups we would like to do more with in the future.
I always find it fascinating to hear details around all the great work that Sanofi US is doing. However, we haven’t even come close to covering all of my discussion with Angela. In our next post, I talk to Angela about prevention efforts with seniors, internal efforts at Sanofi US, and come back to her work with diabetes. I think you’ll continue to really appreciate her perspective.
All the best,